Header Logo

Connection

Matthew Meriggioli to Autoantibodies

This is a "connection" page, showing publications Matthew Meriggioli has written about Autoantibodies.
Connection Strength

1.291
  1. Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol. 2012 Jul; 8(5):427-38.
    View in: PubMed
    Score: 0.382
  2. In vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor. Exp Neurol. 2010 Oct; 225(2):320-7.
    View in: PubMed
    Score: 0.333
  3. Myasthenia gravis with anti-acetylcholine receptor antibodies. Front Neurol Neurosci. 2009; 26:94-108.
    View in: PubMed
    Score: 0.305
  4. Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis. J Autoimmun. 2014 Aug; 52:64-73.
    View in: PubMed
    Score: 0.106
  5. GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis. J Neuroimmunol. 2011 Dec 15; 240-241:65-73.
    View in: PubMed
    Score: 0.091
  6. Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy. Neurol Neuroimmunol Neuroinflamm. 2019 01; 6(1):e523.
    View in: PubMed
    Score: 0.037
  7. Hashimoto encephalopathy with fulminant myocarditis. Pathol Res Pract. 2010 Oct 15; 206(10):720-2.
    View in: PubMed
    Score: 0.021
  8. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. 2004 Dec 28; 63(12):2390-2.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.